Loading...
Doxorubicin
India Pharmaceutical Trade Intelligence
Who Supplies Doxorubicin to India from UNITED STATES
India's doxorubicin imports from UNITED STATES total $320.8K across 19 shipments from 10 foreign suppliers. NEW LIFE MEDICALS (USA),INC. leads with $101.3K in import value; the top 5 suppliers together control 93.3% of this origin. Leading Indian buyers include ALEMBIC PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for doxorubicin — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
NEW LIFE MEDICALS (USA),INC. is the leading Doxorubicin supplier from UNITED STATES to India, with import value of $101.3K across 4 shipments. The top 5 suppliers — NEW LIFE MEDICALS (USA),INC., BAXTER HEALTHCARE SA, NEW LIFE MEDICALS (USA), INC., NEW LIFE MEDICALS (U.S.A.)INC, ACCORD HEALTHCARE INC. — collectively account for 93.3% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEW LIFE MEDICALS (USA),INC. | $101.3K | 4 | 31.6% |
| 2 | BAXTER HEALTHCARE SA | $54.4K | 1 | 17.0% |
| 3 | NEW LIFE MEDICALS (USA), INC. | $53.5K | 1 | 16.7% |
| 4 | NEW LIFE MEDICALS (U.S.A.)INC | $48.1K | 3 | 15.0% |
| 5 | ACCORD HEALTHCARE INC. | $42.1K | 1 | 13.1% |
| 6 | AGRACE PHARMA | $17.8K | 3 | 5.6% |
| 7 | NEW LIFE MEDICALS (USA) INC. | $2.6K | 2 | 0.8% |
| 8 | M/S SUN PHARMACEUTICAL INDUSTRIES INC | $834 | 2 | 0.3% |
| 9 | M/S INGENUS PHARMACEUTICALS | $96 | 1 | 0.0% |
| 10 | CELL SIGNALING TECHNOLOGY | $63 | 1 | 0.0% |
Showing top 10 of 10 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ALEMBIC PHARMACEUTICALS LIMITED | $149.4K | 7 | 46.6% |
| 2 | INTAS PHARMACEUTICALS LIMITED | $95.6K | 2 | 29.8% |
| 3 | CBCC GLOBAL RESEARCH LLP | $54.4K | 1 | 17.0% |
| 4 | HETERO LABS LIMITED | $16.2K | 2 | 5.1% |
| 5 | ZYDUS LIFESCIENCES LIMITED | $4.2K | 3 | 1.3% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $834 | 2 | 0.3% |
| 7 | RICONPHARMA INDIA PRIVATE LIMITED | $96 | 1 | 0.0% |
| 8 | ZELLE BIOTECHNOLOGY PRIVATE LIMITED | $63 | 1 | 0.0% |
Import Statistics
- Import Value
- $320.8K
- Shipments
- 19
- Foreign Suppliers
- 10
- Indian Buyers
- 8
- Avg. Shipment
- $16.9K
Other Doxorubicin Import Origins
Related Analysis
Frequently Asked Questions — Doxorubicin Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Doxorubicin suppliers from UNITED STATES to India?
The top Doxorubicin suppliers from UNITED STATES to India include NEW LIFE MEDICALS (USA),INC., BAXTER HEALTHCARE SA, NEW LIFE MEDICALS (USA), INC.. The leading supplier is NEW LIFE MEDICALS (USA),INC. with import value of $101.3K USD across 4 shipments. India imported Doxorubicin worth $320.8K USD from UNITED STATES in total across 19 shipments.
QHow much Doxorubicin does India import from UNITED STATES?
India imported Doxorubicin worth $320.8K USD from UNITED STATES across 19 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Doxorubicin from UNITED STATES?
The main Indian buyers of Doxorubicin sourced from UNITED STATES include ALEMBIC PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, CBCC GLOBAL RESEARCH LLP. The largest buyer is ALEMBIC PHARMACEUTICALS LIMITED with $149.4K in imports across 7 shipments.
QWhat is the total value of Doxorubicin imports from UNITED STATES to India?
The total value of Doxorubicin imports from UNITED STATES to India is $320.8K USD, across 19 shipments and 10 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Doxorubicin.
- 2.Supplier/Buyer Matching: 10 foreign suppliers from UNITED STATES and 8 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $320.8K aggregated from 19 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
10 suppliers, 8 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists